Pneumocystis carinii pneumonia in gastric cancer patients without acquired immune deficiency syndrome: 3 cases report and literature review.
10.4174/jkss.2012.83.1.50
- Author:
So Young YOON
1
;
Hyun Kyun KI
;
Sung Yong KIM
;
Yo Han CHO
;
Hong Ghi LEE
;
Moon Won YOO
Author Information
1. Department of Hematooncology, Konkuk University Medical Center, Konkuk University School of Medicine, Seoul, Korea.
- Publication Type:Case Report
- Keywords:
Pneumocystis carinii pneumonia;
Gastric cancer;
Chemotherapy
- MeSH:
Acquired Immunodeficiency Syndrome;
Brain;
Dexamethasone;
Hematologic Neoplasms;
Humans;
Neoplasm Metastasis;
Pneumocystis;
Pneumocystis carinii;
Pneumonia, Pneumocystis;
Spinal Cord;
Stomach Neoplasms
- From:Journal of the Korean Surgical Society
2012;83(1):50-55
- CountryRepublic of Korea
- Language:English
-
Abstract:
Pneumocystis carinii pneumonia (PCP) has rarely been reported in solid tumor patients. It is a well-known complication in immunosuppressed states including acquired immune deficiency syndrome and hematologic malignancy. PCP has been reported in solid tumor patients who received long-term steroid treatment due to brain or spinal cord metastases. We found 3 gastric cancer patients with PCP, who received only dexamethasone as an antiemetic during chemotherapy. The duration and cumulative dose of dexamethasone used in each patient was 384 mg/48 days, 588 mg/69 days, and 360 mg/42 days, respectively. These cases highlight that the PCP in gastric cancer patients can successfully be managed through clinical suspicion and prompt treatment. The cumulative dose and duration of dexamethasone used in these cases can be basic data for risk of PCP development in gastric cancer patients during chemotherapy.
